Our firm advises leading acquirers and innovative target companies in strategic transactions, with specific depth in the technology and life sciences sectors.
Our team excels amid the challenge of intricate and complex circumstances. With modern perspectives and commercial expertise, we look at situations holistically and manage all aspects of a deal, not just the legal strategies. CALDWELL’s M&A practice group astutely guides its clients to desirable outcomes across a broad spectrum of industries and geographies, including a full range of cross-border and contested transactions. The group also counsels public companies facing activist shareholders and other complex governance matters.
We partner with startup, growth, and public companies in a range of U.S. and global transactions, including complex divestitures, spinoffs, reverse mergers and special purpose acquisition company (SPAC) transactions. Our team advises clients on industry-shaping deals where traditional business models and cutting-edge technologies intersect. Our team represents all categories of participants in transactions, including buyers, sellers, major stockholders, venture capitalists, lenders, financial advisors, management/founders, special board committees, individual investors, private equity funds, hedge funds and others.
Book a complimentary strategy session with one of our attorneys.